
PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW145221 |
drug action
Pioglitazone Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 15:20 Last Updated: October 07, 2023 at 15:20 |
PW124090 |
signaling
PiotrHomo sapiens
|
Creator: Guest: Anonymous Created On: August 19, 2020 at 02:02 Last Updated: August 19, 2020 at 02:02 |
PW145384 |
drug action
Pipecuronium Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 15:43 Last Updated: October 07, 2023 at 15:43 |
PW176118 |
Pipecuronium Predicted Metabolism Pathway newHomo sapiens
Metabolites of Pipecuronium are predicted with biotransformer.
|
Creator: Omolola Created On: November 29, 2023 at 14:05 Last Updated: November 29, 2023 at 14:05 |
PW127488 |
drug action
Piperacillin Action PathwayStreptococcus pneumoniae (strain ATCC BAA-255 / R6)
Piperacillin is a penicillin beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually gram-positive, organisms. It is combined with tazobactam to treat piperacillin-resistant, piperacillin/tazobactam susceptible, β-lactamase generating strains of several bacteria.
By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, Piperacillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that Piperacillin interferes with an autolysin inhibitor.
|
Creator: Karxena Harford Created On: March 16, 2023 at 04:57 Last Updated: March 16, 2023 at 04:57 |
PW144446 |
drug action
Piperacillin Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 13:39 Last Updated: October 07, 2023 at 13:39 |
PW127441 |
drug action
Piperaquine Action PathwayPlasmodium falciparum
Piperaquine is an antimalarial agent first synthesized in the 1960's and used throughout China. Its use declined in the 1980's as piperaquine resistant strains of Plasmodium falciparum appeared and artemisinin derivatives became available. It has come back into use in combination with the artemisinin derivative Artenimol as part of the combination product Eurartesim.
The mechanism of piperaquine inhibition of the haem detoxification pathway is unknown but is expected to be similar to that of Chloroquine.
|
Creator: Ray Kruger Created On: February 09, 2023 at 11:10 Last Updated: February 09, 2023 at 11:10 |
PW146703 |
drug action
Piperaquine Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 18:50 Last Updated: October 07, 2023 at 18:50 |
PW144708 |
drug action
Piperazine Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 14:16 Last Updated: October 07, 2023 at 14:16 |
PW146107 |
drug action
Piperonyl butoxide Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 17:26 Last Updated: October 07, 2023 at 17:26 |